Fig. 7.
Fig. 7. Dynamics of HIV-1 infection of human PBMCs after prostratin treatment. / PBMCs were exposed to 0.263 μM prostratin, then infected with HIV-1 virion-containing supernatants derived from 293T cells transfected with HIV-1 expression plasmids for the 3 strains as indicated with equivalent p24 antigen input of virus. Supernatant samples were withdrawn on the days after infection, as indicated, and assessed for HIV-1 p24 antigen content by ELISA.

Dynamics of HIV-1 infection of human PBMCs after prostratin treatment.

PBMCs were exposed to 0.263 μM prostratin, then infected with HIV-1 virion-containing supernatants derived from 293T cells transfected with HIV-1 expression plasmids for the 3 strains as indicated with equivalent p24 antigen input of virus. Supernatant samples were withdrawn on the days after infection, as indicated, and assessed for HIV-1 p24 antigen content by ELISA.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal